The first stop for professional medicines advice

Templates

52 results

RelevanceNewest firstOldest firstTitle
Applied filters

UK Health Security Agency (UKHSA) PGD Templates

14 September 2020Patient Group Direction templates by UKHSA are developed for a range of clinical scenarios. A summary of the processes to use and further links are provided.

Using PGDs for administering contrast agents in imaging services

2 April 2019Informing and supporting decision making when considering if a Patient Group Direction (PGD) is an appropriate mechanism for administering contrast agents

Emtricitabine/tenofovir and raltegravir tablets for HIV PEP

5 October 2021SPS PGD template for the supply of emtricitabine/tenofovir disoproxil and raltegravir tablets for HIV Post Exposure Prophylaxis (HIV PEP).

Doxycycline for use within sexual health services

5 October 2021SPS PGD template for supply of doxycycline for the treatment of uncomplicated genital chlamydia trachomatis and non-gonococcal/non-specific urethritis.

Ulipristal acetate 30mg tablets for emergency contraception

4 October 2021SPS PGD template for the supply and/or administration of ulipristal acetate 30mg tablet for emergency contraception.

Combined hormonal contraceptive transdermal patch

5 October 2021SPS PGD template for the supply of combined hormonal transdermal patch for contraception.

Combined hormonal contraceptive vaginal ring

4 October 2021SPS PGD template for the supply of combined hormonal vaginal ring for contraception.

Medroxyprogesterone acetate (SC-DMPA) injection for contraception

5 October 2021SPS PGD template for the supply and/or administration of subcutaneous medroxyprogesterone acetate (SC-DMPA) injection for contraception.

Etonogestrel (e.g. Nexplanon®) implant for contraception

4 October 2021SPS PGD template for the insertion of etonogestrel (e.g. Nexplanon®) 68mg subdermal implant for contraception.

Lidocaine injection for subdermal etonogestrel in contraception

4 October 2021SPS PGD template for administering lidocaine injection to facilitate insertion and/or removal of subdermal etonogestrel (e.g. Nexplanon®) implants.